Home
|
Glossary
|
Site Map
|
Contact Us
about us
product pipeline
technology
clinical trials
investors & news
careers
•
Management
•
Board of Directors
•
Collaborations
•
Brentuximab Vedotin (SGN-35)
•
Lintuzumab (SGN-33)
•
Dacetuzumab (SGN-40)
•
SGN-70
•
SGN-75
•
ASG-5ME
•
Preclinical Programs
•
Scientific Publications
•
ADC Technology
•
SEA Technology
•
Scientific Publications
By Program:
•
Brentuximab Vedotin (SGN-35)
•
Lintuzumab (SGN-33)
•
Dacetuzumab (SGN-40)
•
SGN-70
•
SGN-75
•
ASG-5ME
By Indication:
•
Hodgkin Lymphoma
•
Non-Hodgkin Lymphoma
•
Multiple Myeloma
•
Leukemia/MDS
•
Autoimmune
•
Solid Tumors
•
Press Releases
•
Stock Performance
•
SEC Filings
•
Webcasts & Events
•
Scientific Publications
•
Corporate Governance
•
Analyst Coverage
•
Financial Reports
•
Investor FAQ
•
Information Request
•
Benefits
•
Living in the Area
•
Job Opportunities
INVESTORS & NEWS
•
Press Releases
•
Stock Performance
•
SEC Filings
•
Webcasts & Events
•
Scientific Publications
•
Corporate Governance
•
Analyst Coverage
•
Financial Reports
•
Investor FAQ
•
Information Request
Annual Reports
2009 Annual Report
2008 Annual Report
2007 Annual Report
2006 Annual Report
2005 Annual Report
2004 Annual Report
2003 Annual Report
2002 Annual Report
2001 Annual Report
Quarterly & Other Reports
Q2 2010 Form 10-Q
2010 Proxy Statement
Get help downloading or viewing the above file types
